FDA Approves Giapreza (angiotensin II) to Treat Dangerously Low Blood Pressure

December 21, 2017 — The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock. "Shock, the inability to maintain…Original Article